Exploring new spinal cord stimulation methods for chronic pain relief
Official title: Mechanisms and Outcome-Prognostication for Paresthesia-based and -Free Spinal Cord Stimulation in Patients With Persistent Neuropathic Pain: the MOPPStim Study
Run by University Health Network, Toronto · NCT03852381 · Data updated 2026-11-12
This study is testing new ways of using spinal cord stimulation to see if they can help people with chronic pain feel better compared to traditional methods.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | May 16, 2019 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT03852381 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 80 with refractory neuropathic pain following lumbar spine surgery.
✕Probably not a fit
Patients with previous spinal cord stimulation trials or those with certain medical contraindications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of different spinal cord stimulation (SCS) methods, specifically comparing traditional paresthesia-based SCS with newer paresthesia-free SCS techniques. It aims to understand the mechanisms behind pain relief and identify which patients are most likely to benefit from these treatments. Participants will undergo neuroimaging and assessments to gather data on pain, physical activity, and sleep patterns. The study is designed to be prospective and exploratory, with randomization and blinding to ensure robust results.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management options for patients suffering from chronic neuropathic pain.
How similar studies have gone: While traditional spinal cord stimulation has been widely used, the newer paresthesia-free methods are relatively novel and have not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults, 18 - 80 years of age, with refractory neuropathic pain (as per clinical features and DN4 score \> 3/10) in back and or lower limbs for more than 3 months following lumbar spine surgery 2. Severity of pain \> 3/10 on NRS and ODI score for disability \>40/100; and 3. Pain refractory to conventional medical management tried for at least 3 months. Exclusion Criteria: 1. Age \< 18 or age ≥ 80 years; 2. Previous trial or implantation of SCS system; 3. Procedural contraindications to SCS including extensive thoracolumbar spine surgery, moderate-to-severe central canal stenosis, coagulopathy, local or systemic infection; 4. Pregnancy; 5. Opioid dose \> 200 mg OMED; 6. Psychiatric or psychological disorder likely to impact perception of pain; 7. Inability to comply with the study interventions or evaluate treatment outcomes; 8. Mechanical spine instability as per flexion/extension lumbar X-rays; 9. Ongoing litigation issues related to the pain; and 10. Concomitant peripheral neuropathy or myopathy or central neuropathic pain (e.g. post-stroke pain).
Where it's running
-
Toronto Western Hospital
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Anuj Bhatia, MD FRCPC — University Health Network, Toronto
- Study coordinator: Anuj Bhatia, MD FRCPC
- Email: anuj.bhatia@uhn.ca
- Phone: (416) 603-5800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Progressive resistance exercise to reduce pain in people with multiple sclerosis
This program will test whether 12 weeks of progressive resistance exercise can reduce chronic neuropathic pain in adults with multiple sclerosis.
-
Immune and signaling markers in blood and spinal fluid during spinal cord stimulation for neuropathic pain
This project tests whether measuring immune and signaling molecules in blood and cerebrospinal fluid can help explain and predict how spinal cord stimulation works for adults with chronic neuropathic pain.
-
Refining multiple AI strategies for automatic pain assessment (RUGGI)
This project tests whether AI models using wearable sensors, facial video/thermography, and physiological signals can detect and estimate pain in adults with chronic or cancer-related pain.
-
Assessing nerve activation in spinal cord stimulation for chronic pain
This study looks at how different settings on a spinal cord stimulator affect nerve activity and sensations in patients with chronic pain to help improve pain management.
-
Capsaicin patch for treating chronic pain in children
This study is testing if a special capsaicin patch can help relieve chronic pain in kids aged 12 to 17 who have pain after an injury or surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.